Drug · DIN 01937405
DURAGESIC 75
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 24, 2009; first marketed December 31, 1992.
- Drug Identification Number (DIN)
- 01937405
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Narcotics (CDSA I)
- Dosage form
- Patch
- Route
- Transdermal
- Therapeutic class (ATC)
- Fentanyl N02AB03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FENTANYL | 75 MCG | HOUR |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 7, 1997: NOC 3799New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “duragesic”. A notice may cover another product or only some lots: read it to see what it covers.
- DURAGESIC MAT (fentanyl transdermal system) - Introduction of a Single Ink Colour (Dark Green) on all Strengths of Patches - Notice to HospitalsJuly 28, 2014 · Drugs · Product safety
- DURAGESIC MAT (fentanyl transdermal system) - Introduction of a Single Ink Colour (Dark Green) on all Strengths of Patches - For Health ProfessionalsJuly 28, 2014 · Drugs · Product safety
- DURAGESIC MAT (fentanyl transdermal system) - Introduction of a Single Ink Colour (Dark Green) on all Strengths of Patches - For the PublicJuly 28, 2014 · Drugs · Product safety
- Important safety information on Duragesic (fentanyl transdermal system) - For Health Professionals - Janssen-Ortho Inc. - For Health ProfessionalsSeptember 13, 2005 · Drugs